![](/img/cover-not-exists.png)
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity
E. E. Voest, J. P. Neijt, J. E. E. Keunen, A. W. Dekker, B. S. Asbeck, J. W. R. Nortier, F. E. Ros, J. J. M. MarxVolume:
31
Year:
1993
Language:
english
Pages:
6
DOI:
10.1007/bf00686148
File:
PDF, 1.16 MB
english, 1993